Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T90167 | Target Info | |||
| Target Name | Polyubiquitin-C (UBC) | ||||
| Synonyms | ubiquitin C; HMG20 | ||||
| Target Type | Patented-recorded Target | ||||
| Gene Name | UBC | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US20130237529 | ||||
| Title | Compound That Can Inhibit Ubc13-Uev Interactions, Pharmaceutical Compositions and Therapeutic Uses. | ||||
| Representative Drug(s) | D0B2AE | Drug Info | N.A. | Click to Show More | [1] |
| 2 | D0JA8J | Drug Info | N.A. | [1] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Novel NF-B inhibitors: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):319-34. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.